96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

21 trials found

diseases per page:

Showing 1 to 10 of 21 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001673-93-DK (EUCTR)	07/04/2022	15/02/2022	A study to test long-term treatment with spesolimabin patients with fistulising Crohn’s disease who ...	An open label, long term safety trial of spesolimabtreatment in patients with fistulising Crohn’s di ...	Crohns disease MedDRA version: 20.0;Level: LLT;Classification code 10011408;Term: Crohns disease agg ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim BV	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Hungary;Spain;Belgium;Austria;Denmark;Netherlands;Germany;Korea, Republic of
2	JPRN-jRCT2031210677	18/03/2022	18/03/2022	A study to test whether spesolimabhelps people with Crohn's disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	fibrostenotic Crohn's Disease	Investigational Drug: Spesolimab, Placebo Dose: 1200 mg spesolimabor placebo every 4 weeks (Day 1 to ...	Taguchi Aya	NULL	Pending	>= 18age old	<= 75age old	Both	3	Phase 2	Australia;Austria;Belgium;Brazil;Canada;China;Denmark;France;Germany;Ireland;Israel;Italy;Republic o ...
3	EUCTR2020-005770-99-NO (EUCTR)	20/01/2022	23/09/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim Norway KS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Denmark ...
4	EUCTR2020-005770-99-PT (EUCTR)	17/12/2021	27/09/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim Portugal, Lda	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Austral ...
5	EUCTR2020-005770-99-IT (EUCTR)	24/11/2021	28/09/2021	A study to test whether spesolimabhelps people with Crohn's disease whohave symptoms of bowel obstru ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trialto evaluate spesolimab(BI ...	Fibrostenotic Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Name: BI 655130 Product Code: [BI 655130] INN or Proposed INN: SPESOLIMAB	BOEHRINGER-INGELHEIM ITALIA S.P.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Aruba;A ...
6	EUCTR2020-005770-99-NL (EUCTR)	12/11/2021	05/08/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim	NULL	Not Recruiting			Female: yes Male: yes	100	Phase 2	United States;Serbia;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Italy;Switzerland;France;Denmark ...
7	EUCTR2020-005770-99-IE (EUCTR)	09/11/2021	30/07/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Serbia;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Italy;Switzerland;France;Denmark ...
8	NCT05013385 (ClinicalTrials.gov)	November 9, 2021	13/8/2021	A Study to Test Whether SpesolimabHelps People With Crohn's Disease Who Have Symptoms of Bowel Obstr ...	Multi-center, Double-blind, Randomized, Placebo-controlled, Phase IIa Trial to Evaluate Spesolimab(B ...	Fibrostenotic Crohn´s Disease	Drug: Spesolimab;Drug: Placebo	Boehringer Ingelheim	NULL	Terminated	18 Years	75 Years	All	5	Phase 2	United States;Canada;Japan;Sweden;Austria;Belgium;China;Denmark;France;Germany;Italy;Korea, Republic ...
9	EUCTR2020-005770-99-SE (EUCTR)	20/10/2021	02/09/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Denmark ...
10	EUCTR2020-005770-99-DK (EUCTR)	22/09/2021	20/08/2021	A study to test whether spesolimabhelps people with Crohn’s disease who have symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab(B ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim B.V	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Austral ...

First Previous1 2 3Next Last